Casi Pharmaceuticals Inc Expected To Post A Loss Of 37 Cents A Share: Earnings Preview

CASI Pharmaceuticals

24/03/2023 13:56

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show
a rise in quarterly revenue when it reports  results on March 27
(estimated). 
    * The Rockville Maryland-based  company is expected to
report  a
17.9% increase in revenue to $10.793 million from $9.16 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for CASI
Pharmaceuticals Inc
is for a loss of 37 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $10​, above​ its last closing price
of $1.73. ​​​

This summary was machine generated March 24 at 13:56 GMT.  All
figures in US dollars  unless otherwise stated